AR025569A1 - Pirazol [4,3-d] pirimidinas - Google Patents

Pirazol [4,3-d] pirimidinas

Info

Publication number
AR025569A1
AR025569A1 ARP000104648A ARP000104648A AR025569A1 AR 025569 A1 AR025569 A1 AR 025569A1 AR P000104648 A ARP000104648 A AR P000104648A AR P000104648 A ARP000104648 A AR P000104648A AR 025569 A1 AR025569 A1 AR 025569A1
Authority
AR
Argentina
Prior art keywords
pyrimidins
pirazol
treatment
pyrimidines
pyrazole
Prior art date
Application number
ARP000104648A
Other languages
English (en)
Spanish (es)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR025569A1 publication Critical patent/AR025569A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP000104648A 1999-09-06 2000-09-06 Pirazol [4,3-d] pirimidinas AR025569A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19942474A DE19942474A1 (de) 1999-09-06 1999-09-06 Pyrazolo[4,3-d]pyrimidine

Publications (1)

Publication Number Publication Date
AR025569A1 true AR025569A1 (es) 2002-12-04

Family

ID=7920966

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104648A AR025569A1 (es) 1999-09-06 2000-09-06 Pirazol [4,3-d] pirimidinas

Country Status (23)

Country Link
US (1) US6777419B1 (enExample)
EP (1) EP1210349B1 (enExample)
JP (1) JP4975921B2 (enExample)
KR (1) KR20020025253A (enExample)
CN (1) CN1145627C (enExample)
AR (1) AR025569A1 (enExample)
AT (1) ATE231866T1 (enExample)
AU (1) AU773878B2 (enExample)
BR (1) BR0013781A (enExample)
CA (1) CA2384037C (enExample)
CZ (1) CZ294587B6 (enExample)
DE (2) DE19942474A1 (enExample)
DK (1) DK1210349T3 (enExample)
ES (1) ES2189766T3 (enExample)
HU (1) HUP0202624A3 (enExample)
MX (1) MXPA02002383A (enExample)
NO (1) NO20021083D0 (enExample)
PL (1) PL353366A1 (enExample)
PT (1) PT1210349E (enExample)
RU (1) RU2249594C2 (enExample)
SK (1) SK3132002A3 (enExample)
WO (1) WO2001018004A2 (enExample)
ZA (1) ZA200202653B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031584A1 (de) 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
PL362513A1 (en) * 2000-12-19 2004-11-02 Merck Patent Gmbh Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives
DE10103647A1 (de) * 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
EP1620437B1 (en) 2003-04-29 2009-06-17 Pfizer Limited 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension
US7572799B2 (en) * 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
ATE417849T1 (de) * 2004-04-07 2009-01-15 Pfizer Pyrazoloä4,3-düpyrimidine
EP1881985B1 (en) 2005-05-12 2010-12-29 Pfizer, Inc. Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide
NL2000291C2 (nl) 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
CA2831634C (en) * 2011-04-21 2019-11-12 Origenis Gmbh Pyrazolo [4,3-d] pyrimidines useful as kinase inhibitors
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
US10034861B2 (en) 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
AR113926A1 (es) 2017-12-14 2020-07-01 H Lundbeck As Derivados de 1h-pirazolo[4,3-b]piridinas
RU2020118913A (ru) 2017-12-14 2022-01-14 Х. Лундбекк А/С (H. Lundbeck A/S) Виды комбинированного лечения, предусматривающего введение 1h-пиразолo[4,3-b]пиридинов
US11535611B2 (en) 2017-12-20 2022-12-27 H. Lundbeck A/S Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
US10766893B2 (en) * 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
AU730670B2 (en) * 1997-04-25 2001-03-08 Pfizer Limited Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
DE10060388A1 (de) * 2000-12-05 2002-06-06 Merck Patent Gmbh Verwendung von Pyrazolo [4,3-d]pyrimidinen
DE10103647A1 (de) * 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates

Also Published As

Publication number Publication date
CN1377357A (zh) 2002-10-30
RU2249594C2 (ru) 2005-04-10
DE50001191D1 (de) 2003-03-06
BR0013781A (pt) 2002-05-14
DE19942474A1 (de) 2001-03-15
PT1210349E (pt) 2003-06-30
PL353366A1 (en) 2003-11-17
HUP0202624A3 (en) 2004-11-29
CZ294587B6 (cs) 2005-02-16
JP2003508534A (ja) 2003-03-04
HUP0202624A2 (hu) 2002-12-28
ZA200202653B (en) 2003-09-23
DK1210349T3 (da) 2003-05-19
EP1210349B1 (de) 2003-01-29
CA2384037C (en) 2009-10-13
CN1145627C (zh) 2004-04-14
MXPA02002383A (es) 2002-09-02
KR20020025253A (ko) 2002-04-03
AU7279300A (en) 2001-04-10
WO2001018004A2 (de) 2001-03-15
EP1210349A2 (de) 2002-06-05
CA2384037A1 (en) 2001-03-15
ATE231866T1 (de) 2003-02-15
NO20021083L (no) 2002-03-05
WO2001018004A3 (de) 2001-08-09
AU773878B2 (en) 2004-06-10
NO20021083D0 (no) 2002-03-05
CZ2002736A3 (cs) 2002-05-15
JP4975921B2 (ja) 2012-07-11
ES2189766T3 (es) 2003-07-16
US6777419B1 (en) 2004-08-17
SK3132002A3 (en) 2002-07-02

Similar Documents

Publication Publication Date Title
AR025569A1 (es) Pirazol [4,3-d] pirimidinas
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
ES2052629T3 (es) Pirazolo(3,4-d)piridinas, procedimiento para su preparacion y utilizacion como medicamentos.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
GEP20053511B (en) ) β-Carboline Derivatives Useful as Inhibitors of Phosphodiesterase
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
BRPI0411013A (pt) implante para uso na fusão de estruturas ósseas adjacentes, método de tratar um organismo para promover fusão de estruturas ósseas adjacentes e sistema para uso na fusão de estruturas ósseas adjacentes
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
PA8432901A1 (es) Compuestos de piridilpirrol
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
BR9815409A (pt) Tienopirimidinas
AR028705A1 (es) Bis-arilsulfonas
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
AR024380A1 (es) Tienopirimidinas
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
WO2003031447A3 (de) Pyrimidinderivate mit pde-v hemmender wirkung
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AR028772A1 (es) 5-aminoalquil-pirazol[4,3-d] pirimidinas
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
PA8519501A1 (es) Farnesil transferasa inhibidora del enantiomero de quinolina 1,2-anillado